USPTO serial 99857583
BIOSIGN
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ABID, NABEELA
- Law office
- TMO LAW OFFICE 132
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with BIOSIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Princeton Biomeditech Corporation
Monmouth Junction, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D Olszyk, Jr.
Christopher D Olszyk, Jr. Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pregnancy testing preparations; Pregnancy test kits for home and professional use; Diagnostic reagents for use in veterinary testing for feline leukemia virus, feline immunodeficiency virus, canine heartworm antigen, canine parvovirus, sulfamethazine, foot-and-mouth disease virus, porcine reproductive and respiratory syndrome virus, classical swine fever virus, West Nile virus; Diagnostic reagents for medical purposes for use in the medical testing for rubella, chlamydia, Lyme, streptococcus, infectious mononucleosis, Helicobacter pylori, influenza, SARS-CoV-2, respiratory syncytial virus, salmonella, listeria, Escherischia coli, malaria, Trypanosoma cruzi, Mycoplasma tuberculosis, human immunodeficiency virus, hepatitis, bladder tumor antigen, hemoglobin, thyroid stimulating hormone, follicle stimulating hormone, prostate specific antigen, alpha fetoprotein, carcinoembryonic antigen, pepsinogen, Troponin I, creatine kinase, myoglobin, myosin light chain, C-reactive protein | ACTIVE | Feb 26, 1990 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 1, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 1, 2026 | NWAP | NEW APPLICATION ENTERED | — |